From Benzinga's Biotech Conference: Wedbush Securities VP, Equity Research Andreas Argyrides Says 'Wedbush's Three Top Picks Of The Year Is Ascendis Pharma, Verona Pharma, And United Therapeutics'
Portfolio Pulse from Benzinga Newsdesk
Wedbush Securities VP, Equity Research Andreas Argyrides, has named Ascendis Pharma, Verona Pharma, and United Therapeutics as the firm's top three picks for the year at Benzinga's Biotech Conference.
August 04, 2023 | 1:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ascendis Pharma has been named as one of Wedbush Securities' top picks for the year.
Being named as a top pick by a major securities firm like Wedbush can increase investor interest and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
United Therapeutics has been named as one of Wedbush Securities' top picks for the year.
Being named as a top pick by a major securities firm like Wedbush can increase investor interest and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Verona Pharma has been named as one of Wedbush Securities' top picks for the year.
Being named as a top pick by a major securities firm like Wedbush can increase investor interest and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100